Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Julian Casciano"'
Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States
Autor:
Peter McAllister, Lois Lamerato, Lynda J. Krasenbaum, Joshua M. Cohen, Krishna Tangirala, Stephen Thompson, Maurice Driessen, Julian Casciano, Zenobia Dotiwala, Alexander Mauskop
Publikováno v:
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-8 (2021)
Abstract Background Fremanezumab, a fully humanized monoclonal antibody (IgG2Δa) that selectively targets calcitonin gene-related peptide (CGRP), is approved for migraine prevention in adults. Real-world data on the effectiveness of fremanezumab are
Externí odkaz:
https://doaj.org/article/e6c3c26c5cab4ff2be1b3f2e864869c6
Autor:
Bruce, Bender, John, Oppenheimer, Maureen, George, Randall, Brown, Ayush, Patel, Tanisha, Hill, Amanda, Boe, Ernesto, Mayen Herrera, Zenobia, Dotiwala, Julian, Casciano, Jonathan A, Bernstein
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 10:2941-2948
Previous studies indicate that suboptimal medication adherence may contribute to uncontrolled asthma. Global Initiative for Asthma (GINA) guidelines recommend treatment escalation to biologics for patients with uncontrolled asthma despite adherence t
Autor:
Sarang Rastogi, Jill Davis, Kathleen M. Fox, Lois Lamerato, Gokul Gopalan, Sameer K. Mathur, Julian Casciano, Zenobia Dotiwala
Publikováno v:
Annals of Allergy, Asthma & Immunology. 125:182-189
BACKGROUND Blood eosinophil counts correlate with exacerbations, but there is a lack of consensus on a clinically relevant definition of eosinophil count elevation. OBJECTIVE To analyze health care resource use among patients with elevated blood eosi
Autor:
Asif Shaikh, Swetha R Palli, Giselle Mosnaim, Samir Khoury, Lois Lamerato, Russell A Settipane, Bradley E. Chipps, Gokul Gopalan, Sameer K. Mathur, Julian Casciano, Zenobia Dotiwala
Publikováno v:
Allergy and Asthma Proceedings. 41:248-255
Background: A step-up approach (increasing inhaled corticosteroid [ICS] dose and/or add-on treatment) is recommended for asthma that is uncontrolled despite ICS plus long-acting beta-2‐agonist (LABA) combination treatment. Understanding the impact
Autor:
Randall Brown, Bruce Bender, Amanda Boe, Julian Casciano, Zenobia Dotiwala, Ernesto Mayen Herrera
Publikováno v:
Journal of Allergy and Clinical Immunology. 149:AB90
Autor:
Bruce Bender, Randall Brown, Tanisha Hill, Julian Casciano, Zenobia Dotiwala, Ernesto Mayen Herrera
Publikováno v:
Journal of Allergy and Clinical Immunology. 149:AB89
Autor:
P. McAllister, Joshua T. Cohen, L. Krasenbaum, Zenobia Dotiwala, Julian Casciano, S. Thompson, K. Tangirala, Lois Lamerato
Publikováno v:
Value in Health. 23:S640
Autor:
J M Cohen, S. Thompson, L. Krasenbaum, K. Tangirala, P. McAllister, A Mauskop, Julian Casciano, Lois Lamerato, Zenobia Dotiwala
Publikováno v:
Value in Health. 23:S642
Publikováno v:
Journal of managed carespecialty pharmacy. 23(1)
The European Respiratory Society and American Thoracic Society (ERS/ATS) published guidelines in 2014 for the evaluation and treatment of asthma. These guidelines draw attention to management of patients with asthma that remains uncontrolled despite
Autor:
Bradley C. Martin, Jerry A. Krishnan, Mary Buatti Small, Julian Casciano, Chenghui Li, Zenobia Dotiwala
Publikováno v:
Journal of managed carespecialty pharmacy. 23(1)
Recently published asthma guidelines by the European Respiratory Society and the American Thoracic Society (ERS-ATS) define severe disease based on medication use and control level. These guidelines also emphasize that asthma severity involves certai